Article
18 February 2026 - by Jordan Cates, Julia M. Friedman, Ivan Yen
We highlight changes in value added and key benefit trends for general enrollment plans in the Medicare Advantage market from 2025 to 2026.
Video
18 February 2026 - by Mary Yeh, Jordan Cates, Tyler Copeland
Our experts examine how health plans responded to these 2025 developments and provide insights on how organizations can strategically prepare for 2027, considering ongoing Part D modifications and the implications of the proposed rule.
Article
11 April 2025 - by Julia M. Friedman, Jordan Cates, Chandler Bentley
We examine changes in value-added and key-benefit trends in the Medicare Advantage market from 2024 to 2025, with a focus on dual-eligible special needs plans.
Article
11 April 2025 - by Julia M. Friedman, Jordan Cates, Elizabeth Phillips
In our review of the state of the 2025 Medicare Advantage industry, we highlight changes in value-added and key benefit trends.
Video
12 February 2025 - by Jordan Cates, Julia M. Friedman, Joanne Fontana, Mark Franklin
Over the last year, the Medicare Advantage industry has witnessed significant transformations driven by regulatory shifts and market headwinds that are shaping up to make the 2025 plan year unlike any we have seen before in the MA space.
Article
19 December 2024 - by Julia M. Friedman, Jordan Cates, Chandler Bentley
We examine changes in value-added and key-benefit trends in the Medicare Advantage market from 2024 to 2025, with a focus on dual-eligible special needs plans.
Article
16 December 2024 - by Julia M. Friedman, Jordan Cates, Elizabeth Phillips
In our review of the state of the 2025 Medicare Advantage industry, we highlight changes in value-added and key benefit trends.
Video
13 December 2023 - by James Cooper, Jordan Cates, Tory Carver
This webinar discusses key findings in 2024 mandatory supplemental benefit trends, as plans seek to remain competitive in an evolving Medicare Advantage landscape.
Article
12 September 2023 - by Jordan Cates, Katherine M. Holcomb, Jake K. Klaisner, Ryan Swenson
As CMS moves ahead with the first 10 prescription drugs selected for negotiation for Medicare, we offer some insights, including the impact on plan sponsors.
Article
26 April 2022 - by Jordan Cates, Chandler Bentley, Julia M. Friedman, Adam Barnhart
Lower premiums, richer supplemental benefits, and additional flexibility help drive enrollment gains in an increasingly competitive Medicare Advantage market.